Equity Details
Price & Market Data
Price: $9.12
Daily Change: -$0.391 / 4.28%
Daily Range: $8.81 - $9.94
Market Cap: $859,222,976
Daily Volume: 1,840,026
Performance Metrics
1 Week: 4.20%
1 Month: 11.01%
3 Months: 23.47%
6 Months: -1.83%
1 Year: 58.95%
YTD: -6.83%
About Kura Oncology, Inc. (KURA)
Get a quick summary of Kura Oncology, Inc. (KURA). The stock is priced at 9.12, experiencing a -$0.391 / 4.28% daily shift. Its market capitalization stands at 859,222,976. Track its performance from the last 3 months (23.47%) to the entire year (58.95%).
Company Details
Employees: 260
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.